
Avogran 1mg Tablet DT
Marketer
Cipla Ltd
Salt Composition
Granisetron (1mg)
Overview Avogran 1mg Tablet DT
Granulex 1mg Delayed-Release Tablets are prescribed to alleviate nausea and vomiting stemming from surgery, chemotherapy, or radiation therapy. This medication is not effective against other cancer treatment side effects and offers limited relief from motion sickness. Always adhere to your physician's prescribed dosage and schedule; consistent timing is recommended. Discontinue use only after consulting your doctor. If vomiting occurs within an hour of ingestion, repeat the dose and avoid large meals for the day. Common side effects include headache, bowel irregularities (constipation or diarrhea), and fatigue. Drowsiness and dizziness are also possible; refrain from driving or mentally demanding tasks until the effects are known. These symptoms usually subside upon cessation of treatment; however, persistent or bothersome effects should be discussed with your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing heart or liver conditions, gastrointestinal obstructions, or concurrent medications, particularly those for epilepsy, heart disease, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should seek medical counsel before using this medication.
Primary Ingredients of Avogran 1mg Tablet DT
No information provided. Please provide the text you wish me to rephrase.
Uses of Avogran 1mg Tablet DT
Chemotherapy-induced emesis
Major Benefits of Avogran 1mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Avogran 1mg Tablet DT in water before consumption. While it can be taken with or without food, consistency is key; take it at the same time each day for best results.
Common Side effects of Avogran 1mg Tablet DT:
- Weakness
- Headache
- Constipation
- Diarrhea
- Insomnia (difficulty in sleeping)
How to use Avogran 1mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Avogran 1mg Tablet DT in water before consumption. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Avogran 1mg Tablet DT works:
Avogran 1mg Delayed-Release Tablets counter nausea and vomiting. This antiemetic medication functions by inhibiting serotonin, a neurotransmitter in the brain that can trigger these side effects during chemotherapy or post-surgery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Avogran 1mg Tablet DT with alcohol is undetermined. Seek medical advice before doing so.
PregnancySAFE IF PRESCRIBED
The use of Avogran 1mg Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Avogran 1mg Tablet DT while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Avogran 1mg DT tablets.
KidneySAFE IF PRESCRIBED
Avogran 1mg Tablet DT appears to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, though further study is warranted. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Avogran 1mg Tablet DT in patients with liver disease appears to present a low risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Avogran 1mg Tablet DT :
Should you forget to take your Avogran 1mg Tablet DT, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.
Facts to Know About Avogran 1mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
